WOOREE E&L Haroutine

At a glance

WOOREE E&L Haroutine filed 34 disclosures in the last 12 months, including 1 insider, 1 buyback and 1 issuance. The most recent key filing was on May 26.

Revenue for 2025 was ₩121B, down 17.5% on 2024. Operating margin was 0.2% against 4.7% a year earlier. Debt was 33% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩59.2B and operating loss of ₩10.3B.

The 2025 annual report lists 99 employees with an average tenure of 6.1 years. Its 8 directors and auditors were paid ₩9M each on average. It paid ₩20 per common share in cash dividends. 우리바이오㈜ and related parties held 39.60% at year end.

From the 2025 annual report

Staff: 99 (61 men, 38 women), of whom 0 on fixed-term contracts. Directors and auditors: 8, paid ₩861M in total.

Dividends (common shares)

Largest shareholder

우리바이오㈜ holds 31.69%; with 4 related parties the group holds 39.60% of common shares at year end (from 39.42% at the start of the year).

Auditor: 성현회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary